RecruitingNot applicableNCT04334031

Deployment o the Multidisciplinary Prospective Cohort Imminent

Studying Hereditary angioedema

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Lille
Principal Investigator
David Launay, MD,PhD
University Hospital, Lille
Intervention
Biobanking with genetic analysis(genetic)
Enrollment
2200 enrolled
Eligibility
18 years · All sexes
Timeline
2020 – 2031

Study locations (1)

Collaborators

FHU IMMINeNT · FHU PRECISE: Projet Fédératif Hospitalo-Universitaire PREcision health in Complex Immune-mediated inflammatory diseaSEs · Fond de dotation de la Société Française de Dermatologie (SFD)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04334031 on ClinicalTrials.gov

Other trials for Hereditary angioedema

Additional recruiting or active studies for the same condition.

See all trials for Hereditary angioedema →

← Back to all trials